Wilmington, DE -- (SBWIRE) -- 02/12/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Incyte Corporation (NASDAQ:INCY) and YOU On Demand Holdings, Inc. (NASDAQ:YOD).
Incyte Corporation (NASDAQ:INCY) a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary small molecule drugs for oncology and inflammation is currently up (+4.82%) on 2,696,299 shares traded after Incyte Reported 2013 Fourth-Quarter and Year-End Financial Results; Provided 2014 Financial Guidance; Updated Shareholders on Key Clinical Programs. Incyte Corporation (NASDAQ:INCY) is currently up (+285.35%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Incyte Corporation (NASDAQ:INCY)
YOU On Demand Holdings, Inc. (NASDAQ:YOD) a company that through its subsidiaries, provides integrated value-added service solution and platform for the delivery of pay-per-view, video on demand, and enhanced premium content for cable providers in the People's Republic of China is currently up (+15.78%) on 7,178,150 shares traded after TheStreet Quant Ratings rated YOU On Demand Holdings as a sell. YOU On Demand Holdings, Inc. (NASDAQ:YOD) is currently up (+444.64%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about YOU On Demand Holdings, Inc. (NASDAQ:YOD)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report